Biomarker Assay Validation in Healthy Smokers and COPD Smokers and Ex-smokers

Completed

• Conditions: Asthma; COPD

• Registration Number: NCT02490358
• Lead Sponsor: Respivert Ltd

Brief Summary

This study will collect sputum samples from healthy smokers, COPD smokers and COPD ex-smokers to analyse biomarkers of inflammation

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2015-05-26
• Study Start: 2015-06
• Study First Submitted QC: 2015-07-02
• Study First Posted: 2015-07-03
• Primary Completion: 2016-01
• Study Completion: 2016-01
• Status Verified: 2016-02
• Last Update Submitted: 2016-02-02
• Last Update Posted: 2016-02-03

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 25

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Lipid metabolites in sputum cell homogenate from healthy smokers and smokers and ex-smokers with COPD.	8 months